These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9035100)

  • 1. Amyloid hypothesis of Alzheimer's rides high--for now.
    Schehr RS
    Nat Biotechnol; 1997 Jan; 15(1):19-20. PubMed ID: 9035100
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease aetiology: amyloid and chromosome 14.
    Houlden H; Mullan M
    Br J Hosp Med; 1993 Apr 21-May 4; 49(8):535-6. PubMed ID: 8508237
    [No Abstract]   [Full Text] [Related]  

  • 3. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of intracellular A beta in Alzheimer's disease].
    Tabira T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):175-80. PubMed ID: 12451689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bad seed in Alzheimer's disease.
    Fryer JD; Holtzman DM
    Neuron; 2005 Jul; 47(2):167-8. PubMed ID: 16039556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.
    Lee JY; Friedman JE; Angel I; Kozak A; Koh JY
    Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
    Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
    Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's theory makes a splash.
    Schnabel J
    Nature; 2009 May; 459(7245):310. PubMed ID: 19458681
    [No Abstract]   [Full Text] [Related]  

  • 11. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.
    Wirths O; Multhaup G; Bayer TA
    J Neurochem; 2004 Nov; 91(3):513-20. PubMed ID: 15485483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve inflammation halts trial for Alzheimer's drug.
    Check E
    Nature; 2002 Jan; 415(6871):462. PubMed ID: 11823817
    [No Abstract]   [Full Text] [Related]  

  • 14. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.
    Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP
    Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease.
    Augustin S; Rimbach G; Augustin K; Schliebs R; Wolffram S; Cermak R
    Arch Biochem Biophys; 2009 Jan; 481(2):177-82. PubMed ID: 18996078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond amyloid: the next generation of Alzheimer's disease therapeutics.
    Seabrook GR; Ray WJ; Shearman M; Hutton M
    Mol Interv; 2007 Oct; 7(5):261-70. PubMed ID: 17932415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology: infectious Alzheimer's disease?
    Riek R
    Nature; 2006 Nov; 444(7118):429-31. PubMed ID: 17122841
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.